J & J to buy Santa Clara-based Shockwave for $13 billion in medical device play https://ift.tt/JLz3SYH J&J has been rapidly building its portfolio in both medical technology and drug development to help prepare for the impending loss of exclusivity for Stelara, its top-selling drug for psoriasis…

.